Clinica Universidad de Navarra
Clinica Universidad de Navarra is a Spanish private non-profit academic medical center operating two hospital campuses (Pamplona and Madrid) with 4,000+ professionals across 50+ departments and specialties, delivering advanced oncology care, clinical research, and medical education through integration with Universidad de Navarra.
- Company typePrivate
- Founded1961
- HeadquartersPamplona, Spain
- Headcount1,001–5,000
- GTM typeB2C
- OfferingServices
What Clinica Universidad de Navarra does
Clinica Universidad de Navarra (CUN) is a Spanish private, non-profit academic medical center founded in 1961, operating two hospital campuses in Pamplona (Navarra) and Madrid with more than 4,000 professionals organized across 50+ departments and medical services. The institution is integrated with Universidad de Navarra and CIMA Universidad de Navarra, its dedicated biomedical research institute, and runs the CUN Academia education division, creating a unified clinical-care, research, and teaching platform anchored on a university hospital model.
The clinical product portfolio centers on advanced oncology — including Europe's first Hitachi synchrotron proton therapy unit, MR Linac MRI-guided radiotherapy, Da Vinci robotic surgery (including a Da Vinci Single Port system installed at Madrid in January 2026), and HIFU for essential tremor and Parkinson's disease — supplemented by whole-genome sequencing (Veritas/Illumina), health-check programs, second-opinion consultations, and a dedicated international patient services channel. Technology investments announced in 2024 add three surgical robots, two MRI machines, and a proton/radiotherapy CT scanner. CUN runs more than 200 active clinical trials and, as of March 2026, operates an AI-assisted patient-trial matching system through a partnership with myTomorrows that uses large language models to analyze structured and unstructured clinical data against protocol eligibility criteria inside CUN's electronic health record.
CUN generates revenue primarily through fee-for-service medical care (consultations, diagnostics, surgeries, hospitalizations), clinical-trial partnerships with pharmaceutical sponsors, preventive health-check and genomic-screening programs, and international patient services. Pricing is quote-based and not publicly disclosed. The institution holds Joint Commission International accreditation continuously since 2004 (eighth reaccreditation in Pamplona in 2026 and first for Madrid in 2024), Magnet nursing recognition (first Magnet hospital in Spain), ISO 27001 certification, and ranks in the global top 50 in Newsweek's World's Best Specialized Hospitals 2026 across Gastroenterology, Neurology, Medical Oncology, and Orthopedic Surgery, plus rank 78 in World's Best Smart Hospitals.
Clinica Universidad de Navarra firmographics
Firmographics- Name
- Clinica Universidad de Navarra
- Legal name
- CLÍNICA UNIVERSIDAD DE NAVARRA
- Website
- https://cun.es
- Company type
- Private
- Founded year
- 1961
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Clinica Universidad de Navarra is a Spanish private non-profit academic medical center operating two hospital campuses (Pamplona and Madrid) with 4,000+ professionals across 50+ departments and specialties, delivering advanced oncology care, clinical research, and medical education through integration with Universidad de Navarra.
- Ownership category
- akta.pro rank
Clinica Universidad de Navarra industry classification
Industry- Product category
- Hospital and Specialty Healthcare Services
- NAICS
- General Medical and Surgical Hospitals (622110), Specialty (except Psychiatric and Substance Abuse) Hospitals (6223), Medical Laboratories (621511), General Medical and Surgical Hospitals (6221)
- SIC
- Services-General Medical & Surgical Hospitals, Nec (8062), Services-Medical Laboratories (8071), Services-Health Services (8000)
- akta.pro primary industry
- Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM)
- akta.pro secondary industries
- Oncology & Cancer Specialty Hospitals (HLAFAHAC), Clinical Research & Trial Central Laboratories (HLAFAMAL), Point-of-Care & Decentralized Trial Testing Services (HLAGAEAK)
Keywords
Where Clinica Universidad de Navarra is headquartered
LocationHeadquarters
- HQ city
- Pamplona
- HQ country
- Spain
- HQ region
- Europe
Offices2 records
Markets served
Clinica Universidad de Navarra business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales, Supply Chain
Revenue model
- Medical Services Revenue: Revenue generated from comprehensive medical services including consultations, diagnostics, treatments, surgeries, hospitalizations, and specialized therapies across 50+ departments and services.
- Clinical Trials: Revenue from conducting clinical trials in partnership with pharmaceutical companies and research institutions, supported by CIMA Universidad de Navarra research center.
- Health Check Programs: Preventive medicine and health check-up programs including genomic screening, cardiovascular checks, and cancer early detection programs.
- International Patient Services: Specialized services for international patients including medical consultations, treatment coordination, travel assistance, and accommodation support.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Pay-as-you-go | General medical consultations and diagnostics |
| Other | Multi-year contract | Specialized treatments and surgeries |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels7 records
Clinica Universidad de Navarra product offering
Product offeringCore offering
Clinica Universidad de Navarra (CUN) is a private, non-profit academic medical center operating two hospital campuses in Pamplona and Madrid, providing comprehensive specialized medical care across 50+ departments and services. Its core offerings include advanced oncology treatments (proton therapy, MR Linac, immunotherapy), robotic surgery (Da Vinci and Da Vinci Single Port), HIFU for neurological conditions, whole genome sequencing, preventive health check-ups, and access to more than 200 active clinical trials, supported by an integrated research institute (CIMA) and academic training division (CUN Academia).
Product overview
Clinica Universidad de Navarra (CUN) is a comprehensive medical center operating as a unified healthcare platform with two locations (Pamplona/Navarra and Madrid) serving over 4,000 professionals across more than 50 departments. The organization offers an integrated portfolio combining clinical care, research (through Cima Universidad de Navarra), and education (through CUN Academia). Key products and services include: AI-powered clinical trial matching (using large language models for patient-trial matching), whole genome sequencing programs, proton therapy (with Europe's first Hitachi synchrotron), MR Linac radiation therapy, Da Vinci robotic surgery (including Single Port SP system), HIFU for neurological conditions, and specialized cancer care through the Cancer Center. The institution also operates CIMA LAB Diagnostics for laboratory services and maintains social programs like Niños Contra el Cáncer. Recent additions include the Da Vinci Single Port surgical robot (January 2026) and myTomorrows AI partnership (March 2026) for enhanced clinical trial infrastructure.
Differentiator
Problem solved
Functional benefit
Brands
- Cancer Center Clínica Universidad de Navarra: The hospital's dedicated cancer care center offering comprehensive oncology services including proton therapy, immunotherapy, and advanced treatments.
- CIMA Universidad de Navarra
- Niños Contra el Cáncer
- CUN Academia
- CIMA LAB Diagnostics
Products and services
- Proton Therapy (Protonterapia) State-of-the-art proton therapy treatment for cancer using the first Hitachi synchrotron in Europe, providing precise radiation targeting to minimize damage to surrounding healthy tissue. For cancer patients requiring advanced radiotherapy.
- MR Linac (MRI-Guided Linear Accelerator) Radiation therapy accelerator guided by 1.5 Tesla MRI providing high diagnostic precision before, during, and after treatment for precise cancer treatment delivery. For oncology patients.
- Da Vinci Robotic Surgery Robotic surgical system providing greater surgical precision, less invasive procedures, and elimination of natural hand tremor for enhanced surgical outcomes across multiple specialties.
- Da Vinci Single Port (SP) Robotic Surgery Single-port robotic surgery system allowing complex interventions through a single 3-5 cm incision or natural body orifices, with 3D HD vision and articulated instruments. Currently used for urological procedures (prostatectomy) and thoracic surgery.
- HIFU (High-Intensity Focused Ultrasound) for Tremor and Parkinson Non-surgical treatment for essential tremor and Parkinson's disease symptoms using high-intensity focused ultrasound technology. For neurology patients.
- Whole Genome Sequencing Program (myGenome Test) Elective genomic screening program using Veritas Intercontinental's myGenome test and Illumina sequencing technology to sequence whole genomes of adults and identify clinically relevant variants, including ACMG secondary findings.
- AI-Powered Clinical Trial Matching System AI-assisted patient-trial matching system using large language models to analyze structured clinical variables and unstructured medical documentation, cross-referencing patient information against protocol-defined eligibility criteria and real-time cohort status, integrated into the hospital's electronic health record.
- Medical Check-ups and Predictive Medicine Comprehensive health check-up programs including medical check-ups, cardiovascular checks, cancer early detection, genomic screening, and preventive medicine services for individuals seeking health assessments.
- Genes y Salud (Genomic Health Program) Comprehensive genomic health program including genetic inheritance analysis, genetic counseling, genetic disease diagnosis, treatment and genomic medicine, and genetic research for patients seeking personalized genomic care.
- Cancer Center Clinica Universidad de Navarra Comprehensive oncology center integrating interdisciplinary cancer care, personalized medicine, and clinical and preclinical research, with specialized areas for different cancer types. For oncology patients seeking integrated cancer care.
- Prostate Center Specialized prostate center offering diagnosis and treatment of prostate conditions, including focal therapy and robotic surgery. For patients with prostate conditions.
- Remote Second Opinion Consultations Remote second opinion service allowing patients to receive specialist consultations, including oncology second opinions, without traveling to Spain.
- Advanced Therapies Unit (Unidad de Terapias Avanzadas) Advanced therapy research and clinical care unit developing innovative treatments for cancer and other complex diseases, including immunotherapy and gene therapy.
Quantifiable outcome
- Top 50 global ranking in Gastroenterology (20), Neurology (40), Medical Oncology (44), and Orthopedic Surgery (50) by Newsweek World's Best Specialized Hospitals 2026
- +4 more outcomes
Companies that use Clinica Universidad de Navarra
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles4 records
Clinica Universidad de Navarra technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability10 records
Feature6 records
Clinica Universidad de Navarra partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- myTomorrowscorePartnership to implement AI-assisted patient-trial matching across CUN's portfolio of over 200 active clinical trials in Spain. The AI system uses large language models to analyze structured clinical variables and unstructured medical documentation, cross-referencing patient information against protocol-defined eligibility criteria and real-time cohort status directly within CUN's electronic health record. This is myTomorrows' first large-scale site partnership in Spain. The collaboration also includes enhanced referral coordination between CUN and external institutions through a CUN-branded website powered by myTomorrows' technology.
Scale indicators7 records
Recent moves6 records
Expansion highlights6 records
Clinica Universidad de Navarra competitors and assessment
Company assessmentDirect peers
- Hospital Universitario La Paz: Madrid-based public university hospital and one of Spain's leading academic medical centers. Comparable to CUN as a high-complexity tertiary referral hospital with strong oncology, research output, and teaching mission, although publicly funded rather than private non-profit.
- Hospital Clinic Barcelona: Leading Spanish university hospital with international reputation in oncology, gastroenterology, and translational research. Closely comparable to CUN as a tertiary academic medical center combining clinical care, research, and teaching.
- Hospital Universitario Vall d'Hebron: Largest hospital complex in Catalonia and one of Spain's top-ranked academic centers. Comparable to CUN in scale (~4,000+ professionals), oncology leadership, and integrated research-clinical model.
- Hospital Ruber Internacional: Madrid-based private tertiary hospital known for advanced technology and international patient services. Directly competes with CUN Madrid for private and international patients seeking high-acuity specialty care in Spain.
- Centro Médico Teknon: Barcelona-based private hospital (Quirónsalud group) with strong oncology and robotic surgery programs and an established international patient office. Comparable to CUN in private tertiary care positioning and inbound medical tourism.
Broad incumbents
- Quirónsalud: Spain's largest private hospital group, with broad specialty coverage and a network of flagship centers including advanced oncology. Comparable to CUN as a competitor in private tertiary care, but operates a multi-site for-profit network rather than a single academic medical center.
- MD Anderson Cancer Center: Global leader in oncology care, research, and proton therapy. Comparable to CUN's Cancer Center in advanced radiation oncology (including proton therapy), clinical trial scale, and academic integration — and serves as the global benchmark CUN references in rankings.
- Charité – Universitätsmedizin Berlin: One of Europe's largest university hospitals with a strong oncology and translational research profile. Comparable to CUN as a European academic medical center combining patient care, research, and teaching at scale.
- Karolinska University Hospital: Nordic region's leading academic hospital affiliated with Karolinska Institutet. Comparable to CUN in the academic-medical-center model, international patient programs, and high-acuity specialty care including oncology and proton therapy.
Others
- Veritas Intercontinental: Genomics partner whose myGenome whole-genome sequencing test underpins CUN's elective genomic screening program. Comparable as an enabling partner in CUN's precision medicine offering rather than a direct competitor.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Clinica Universidad de Navarra social profiles
Digital presenceClinica Universidad de Navarra compliance and trust
Trust signalCompliance6 records
Clinica Universidad de Navarra financial estimates
Financial estimateRevenue estimate
Valuation estimate
Clinica Universidad de Navarra leadership team
Management profileNumber of profiles
Profiles13 records
Clinica Universidad de Navarra funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Clinica Universidad de Navarra M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Clinica Universidad de Navarra
What does Clinica Universidad de Navarra do?
Clinica Universidad de Navarra (CUN) is a private, non-profit academic medical center operating two hospital campuses in Pamplona and Madrid, providing comprehensive specialized medical care across 50+ departments and services. Its core offerings include advanced oncology treatments (proton therapy, MR Linac, immunotherapy), robotic surgery (Da Vinci and Da Vinci Single Port), HIFU for neurological conditions, whole genome sequencing, preventive health check-ups, and access to more than 200 active clinical trials, supported by an integrated research institute (CIMA) and academic training division (CUN Academia).
Is Clinica Universidad de Navarra a public or private company?
Clinica Universidad de Navarra is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Clinica Universidad de Navarra founded?
Clinica Universidad de Navarra was founded in 1961. It employs 1,001 to 5,000 people.
Where is Clinica Universidad de Navarra based?
Clinica Universidad de Navarra is headquartered in Pamplona, Spain, in the Europe region.
How does Clinica Universidad de Navarra make money?
Four revenue lines are on record. Medical Services Revenue is the primary driver. The others are clinical Trials, health Check Programs and international Patient Services.
Who are Clinica Universidad de Navarra's main competitors?
Direct peers on record are Hospital Universitario La Paz, Hospital Clinic Barcelona, Hospital Universitario Vall d'Hebron, Hospital Ruber Internacional and Centro Médico Teknon. Broad incumbents are Quirónsalud, MD Anderson Cancer Center, Charité – Universitätsmedizin Berlin and Karolinska University Hospital. Veritas Intercontinental is listed as an others.
Does Clinica Universidad de Navarra have an API?
No public API is recorded for Clinica Universidad de Navarra.
What industry is Clinica Universidad de Navarra in?
Clinica Universidad de Navarra's product category is Hospital and Specialty Healthcare Services. Its primary akta.pro industry code is HLAFAAAM, Hospital-Integrated Cancer Centers (Acute Oncology Programs), with a secondary code of HLAFAHAC, Oncology & Cancer Specialty Hospitals. Its NAICS code is 622110 and its SIC code is 8062.